Company Spring Pharmaceutical Group, Inc.

BYC

US84987P1057

Managers

Members of the board

Share class

Company contact information

Sector

Sector Other Pharmaceuticals

Inactive Instrument

SPRING PHARMACEUTICAL GROUP, INC., formerly China YCT International Group, Inc., operates through two of its subsidiaries, Landway Nano Bio-Tech Group, Inc. (Landway Nano) and Shandong Spring Pharmaceutical Co., Ltd. (Shandong Spring Pharmaceutical). Through its subsidiaries, the Company is engaged in the distribution of health care supplement products, and in the development, manufacture and sales of Huoliyuan capsules, and in the development of the acer truncatum bunge planting bases and selling acer truncatum seed oil.

Managers	Title	Age	Since
Ting He Yan CEO	Chief Executive Officer	69	01/89/01
Chuan Min Li DFI	Director of Finance/CFO	59	01/05/01
Qiang Zhang ADM	Chief Administrative Officer	52	-
Ji Rui Zhang BRD	Director/Board Member	68	01/04/01
Xu Zhong Ding SAM	Sales & Marketing	52	01/03/01
Ze Cheng Shao PRN	Corporate Officer/Principal	51	-

Members of the board	Title	Age	Since
Ting He Yan CEO	Chief Executive Officer	69	01/89/01
Ji Rui Zhang BRD	Director/Board Member	68	01/04/01
Robert J. Fanella BRD	Director/Board Member	73	06/09/06
Wen Gao Zhang BRD	Director/Board Member	79	06/09/06
Dong Li BRD	Director/Board Member	35	01/17/01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	0	45	0	0	61.81 %
Stock B	1	29,839,168	18,444,602 ( 61.81 %)	0

Spring Pharmaceutical Group, Inc.

Gucheng Road

373200, Sichui

http://www.yctgroup.com

address Spring Pharmaceutical Group, Inc.(BYC)

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Other Pharmaceuticals

	1st Jan change	Capi.
ELI LILLY AND COMPANY	+40.73%	739B
NOVO NORDISK A/S	+32.83%	598B
JOHNSON & JOHNSON	-6.30%	353B
MERCK & CO., INC.	+15.15%	318B
ABBVIE INC.	+4.05%	285B
ASTRAZENECA PLC	+15.00%	240B
NOVARTIS AG	+9.78%	210B
ROCHE HOLDING AG	-5.52%	206B
AMGEN INC.	+6.17%	164B

Other Pharmaceuticals